medigraphic.com
ISSN 1405-1710 (Impreso)

2020, Número 1

<< Anterior Siguiente >>

Rev Cent Dermatol Pascua 2020; 29 (1)


Acropigmentación reticulada de Kitamura

Olguín-García MG, Palacios-Reyes MC, González-González M, Marmolejo-Chavira M

Idioma: Español
Referencias bibliográficas: 18
Paginas: 10-15
Archivo PDF: 361.94 Kb.


RESUMEN

En este artículo se comunica el caso de una mujer de 29 años de edad, quien acude por presentar en dorso de manos y pies múltiples manchas de color café en distintos tonos, milimétricas, bien delimitadas, que confluyen en un patrón reticular; algunas de ellas se ubican sobre áreas de atrofia. Además, se observan hoyuelos palmares (pits) que siguen e interrumpen el trayecto de los dermatoglifos. El cuadro es asintomático, benigno y corresponde a una genodermatosis de carácter autosómica dominante poco frecuente denominada acropigmentación reticulada de Kitamura (ARK).


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Kitamura K ASNS HIFU shikisoijo. RNHH. No Title. 1943; 8: 4.

  2. OMIM. Reticulate acropigmentation of Kitamura (RAK). p. #615537.

  3. Al Hawsawi K, Al Aboud K, Alfadley A, Al Aboud D. Reticulate, acropigmentation of Kitamura & Dowling Degos disease overlap: a case report. Int J Dermatol. 2002; 41: 518-520.

  4. Rathoriya S, Soni SL, Asati D. Dowling-Degos disease with reticulate acropigmentation of Kitamura: extended spectrum of a single entity. Indian Dermatol Online J. 2016; 7: 32-35.

  5. Müller CSL, Pföhler C, Tilgen W. Changing a concept-controversy on the confusing spectrum of the reticulate pigmented disorders of the skin. J Cutan Pathol. 2009; 36: 44-48.

  6. Kono M, Sugiura K, Suganuma M, Hayashi M, Takama H, Suzuki T et al. Whole-exome sequencing identifies ADAM10 mutations as a cause of reticulate acropigmentation of Kitamura, a clinical entity distinct from Dowling-Degos disease. Hum Mol Genet. 2013; 22: 3524-3533.

  7. Kono M, Suganuma M, Takama H, Suzuki T, Matsunaga K, Tomita Y et al. Dowling-Degos disease is genetically and clinico-pathologically distinct from reticulate acropigmentation of Kitamura, further confirmation. J Dermatol Sci. 2016; 84: e81.

  8. Prevalence and incidence of rare diseases: bibliographic data. 2017: 1-74. Orphadata databese, www.orphadata.org.

  9. Kawaguchi M, Hearing VJ. The roles of ADAMs family proteinases in skin diseases. Enzyme Res. 2011; 2011: 1-9.

  10. Kawaguchi M, Hozumi Y, Suzuki T. ADAM protease inhibitors reduce melanogenesis by regulating PMEL17 processing in human melanocytes. J Dermatol Sci. 2015; 78: 133-142.

  11. Okamura K, Abe Y, Araki Y, Hozumi Y, Kawaguchi M, Suzuki T. Behavior of melanocytes and keratinocytes in reticulate acropigmentation of Kitamura. Pigment Cell Melanoma Res. 2016; 29: 243-246.

  12. Koguchi H, Ujiie H, Aoyagi S, Osawa R, Shimizu H. Characteristic findings of handprint and dermoscopy in reticulate acropigmentation of Kitamura. Clin Exp Dermatol. 2014; 39: 85-87.

  13. Calonje JE, Brenn T, Phillip MA. McKee’s pathology of the skin. 4th ed. China: Saunders; 2011. p. 1906.

  14. Kameyama K, Morita M, Sugaya K, Nishiyama S, Hearing VJ. Treatment of reticulate acropigmentation of Kitamura with azelaic acid. An immunohistochemical and electron microscopic study. J Am Acad Dermatol. 1992; 26: 817-820.

  15. Fahad AS, Shahwan HA, Dayel SB. Treatment of reticulated acropigmentation of Kitamura with Q-switched alexandrite laser. Int J Dermatol. 2011; 50: 1150-1152.

  16. Hyung Lee J, Hee Lee J, Heung Lee J. A case of reticulate acropigmentation of Kitamura treated with 532-nm Q-Switched Nd: YAG Laser: 10 years of follow-up observation. Ann Dermatol. 2014; 26: 783-785.

  17. Wu YH, Lin YC. Generalized Dowling-Degos disease. J Am Acad Dermatol. 2007; 57: 327-334.

  18. Mehta D, Raval N, Patadiya H, Tarsariya V. Gorlin-Goltz syndrome. Ann Med Health Sci Res. 2014; 4: 279-282.




2020     |     www.medigraphic.com